Tolazamide

In the US, Tolazamide (tolazamide systemic) is a member of the drug class sulfonylureas and is used to treat Diabetes, Type 2.

US matches:

• Tolazamide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BB05

CAS registry number (Chemical Abstracts Service)

0001156-19-0

Chemical Formula

C14-H21-N3-O3-S

Molecular Weight

311

Therapeutic Category

Oral antidiabetic agent, sulfonylurea

Chemical Name

Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-

Foreign Names

• Tolazamidum (Latin)
• Tolazamid (German)
• Tolazamide (French)
• Tolazamida (Spanish)

Generic Names

• Tolazamide (OS: USAN, JAN, DCIT, DCF, BAN)
• U 17835 (IS)
• Tolazamide (PH: JP XIV, USP 32, BP 2010)

Brand Names

• Esulin
  Chung Mei, Taiwan



• Tolazamide
  Mylan, United States; Sandoz, United States; Watson, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.